SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-13-000152
Filing Date
2013-07-31
Accepted
2013-07-31 16:02:29
Documents
1
Period of Report
2013-04-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 15415
  Complete submission text file 0001192482-13-000152.txt   17169
Mailing Address
Business Address 2 GREENVILLE CROSSING 4005 KENNETT PIKE STE 220 GREENVILLE DE 19807
QUAKER BIO VENTURES LP (Reporting) CIK: 0001170144 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54852 | Film No.: 13999026

Mailing Address
Business Address 435 DOVER PARK DRIVE BLDG 500 WAYNE PA 19087 2159886811
QUAKER BIOVENTURES CAPITAL LP (Reporting) CIK: 0001223034 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54852 | Film No.: 13999025

Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Issuer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations